Biotronik Inc.

6024 Jean Road

Lake Oswego

97035-5369

USA

800-547-0394

800-291-0470

[email protected]

http://www.biotronikusa.com

Product Categories

Remote Monitoring, Pacemakers, Cardiac Resynchronization Therapy Devices (CRT), Leads Implantable Devices

Related Content

Biotronik's closed loop stimulation (CLS) technology helps reduce unexplained fainting in patients with recurrent episodes due to skipped heartbeats. #ESC2020

News | EP Lab

Study Shows Severe Fainting Can Be Treated with Cardiac Pacing Supported by Closed Loop Stimulation

September 8, 2020 - A new study presented at the 2020 European Society of Cardiology (ESC) Congress shows that Biotronik ...

September 08, 2020

Biotronik Launchs His-Bundle Pacing Tools

News | Pacemakers

Biotronik Launches His-Bundle Pacing Tools

June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His ...

June 16, 2020

he Actus AcQMap EP 3-D mapping catheter used to speed electromapping and procedure times.

News | EP Lab

Biotronik Partners With Acutus Medical to Offer More Efficient Arrhythmia Diagnosis and Treatment

May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of ...

May 20, 2020

Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.

Feature | Cardiac Resynchronization Therapy Devices (CRT)| Valentina Kutyifa M.D., Ph.D.

BIO-LIBRA Study Evaluates Role of Sex and Device Type in Non-ischemic Cardiomyopathy

Cardiovascular disease is the leading cause of death for women in North America, and women with heart failure often ...

March 09, 2020

Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the 2020 Cardiovascular Research Technologies (CRT) Congress. The three-year follow-up data demonstrates consistently lower clinical event rates and improvement in patient outcomes, reinforcing the differentiation of the Orsiro coronary drug-eluting stent (DES), which is the first DES to outperform Xience.

News | Stents

Biotronik's Orsiro Stent Continues Excellent Results After Three Years

February 24, 2020 — Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the ...

February 24, 2020

Superiority of Orsiro Over Xience Demonstrated in STEMI Patients

News | Stents Drug Eluting

Superiority of Orsiro Over Xience Stent Demonstrated in STEMI Patients

September 5, 2019 — Biotronik's ultrathin Orsiro stent demonstrated superiority over Xience with respect to target ...

September 05, 2019

Biotronik Launches Biomonitor III Injectable Cardiac Monitor in the CE Region

News | Implantable Cardiac Monitor (ICM)

Biotronik Launches Biomonitor III Injectable Cardiac Monitor in Europe

July 1, 2019 – Biotronik announced the European market release of its new injectable cardiac monitor (ICM), Biomonitor ...

July 01, 2019

A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.

Feature | Implantable Cardioverter Defibrillator (ICD)| Dave Fornell, Editor

New Technology and Market Challenges Facing Implantable Cardioverter Defibrillators

This is a brief overview of updates on implantable cardioverter defibrillators (ICD), including new technology ...

May 24, 2019

News | Cardiac Resynchronization Therapy Devices (CRT)

Biotronik Launches Acticor DX and CRT-DX Devices in U.S.

April 29, 2019 — Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX and ...

April 29, 2019

News | Cardiac Resynchronization Therapy Devices (CRT)

Biotronik Launches Acticor and Rivacor ICD and CRT-D Devices in Europe

April 18, 2019 – Biotronik announced the European market release of what it calls the world’s smallest implantable ...

April 18, 2019